70 related articles for article (PubMed ID: 25381700)
21. Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
Ben Arush M; Minard-Colin V; Mosseri V; Defachelles AS; Bergeron C; Algret N; Fasola S; André N; Thebaud E; Corradini N; Bernier V; Martelli H; Ranchère D; Orbach D
Eur J Cancer; 2015 Jan; 51(2):193-201. PubMed ID: 25471261
[TBL] [Abstract][Full Text] [Related]
22. A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.
Perez-Andreu V; Roberts KG; Xu H; Smith C; Zhang H; Yang W; Harvey RC; Payne-Turner D; Devidas M; Cheng IM; Carroll WL; Heerema NA; Carroll AJ; Raetz EA; Gastier-Foster JM; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Rowe JM; Luger SM; Tallman MS; Dean M; Burchard EG; Torgerson DG; Yue F; Wang Y; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Loh ML; Willman CL; Hunger SP; Mullighan CG; Yang JJ
Blood; 2015 Jan; 125(4):680-6. PubMed ID: 25468567
[TBL] [Abstract][Full Text] [Related]
23. A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor.
Mahadeo KM; Weinberg KI; Abdel-Azim H; Miklos DB; Killen R; Kohn D; Crooks GM; Shah AJ; Kharbanda S; Agarwal R; Kapoor N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):440-4. PubMed ID: 25459642
[TBL] [Abstract][Full Text] [Related]
24. Sarcomas.
HaDuong JH; Martin AA; Skapek SX; Mascarenhas L
Pediatr Clin North Am; 2015 Feb; 62(1):179-200. PubMed ID: 25435119
[TBL] [Abstract][Full Text] [Related]
25. Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.
Sklavos MM; Stratton P; Giri N; Alter BP; Savage SA; Pinto LA
J Clin Endocrinol Metab; 2015 Feb; 100(2):E197-203. PubMed ID: 25405500
[TBL] [Abstract][Full Text] [Related]
26. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Dreyer ZE; Hilden JM; Jones TL; Devidas M; Winick NJ; Willman CL; Harvey RC; Chen IM; Behm FG; Pullen J; Wood BL; Carroll AJ; Heerema NA; Felix CA; Robinson B; Reaman GH; Salzer WL; Hunger SP; Carroll WL; Camitta BM
Pediatr Blood Cancer; 2015 Mar; 62(3):419-26. PubMed ID: 25399948
[TBL] [Abstract][Full Text] [Related]
27. Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography.
Ryerson AB; Border WL; Wasilewski-Masker K; Goodman M; Meacham L; Austin H; Mertens AC
Pediatr Blood Cancer; 2015 Mar; 62(3):502-8. PubMed ID: 25393686
[TBL] [Abstract][Full Text] [Related]
28. Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
Amenábar JM; Torres-Pereira CC; Tang KD; Punyadeera C
Cancer; 2019 Nov; 125(22):3936-3946. PubMed ID: 31390058
[TBL] [Abstract][Full Text] [Related]
29. Liver abnormalities are frequent and persistent in patients with Fanconi anemia.
Snyder AJ; Campbell KM; Lane A; Mehta PA; Myers K; Davies SM; Koo J
Blood Adv; 2024 Mar; 8(6):1427-1438. PubMed ID: 38231120
[TBL] [Abstract][Full Text] [Related]
30. Maternal anemia and the risk of childhood cancer: A population-based cohort study in Taiwan.
Orimoloye HT; Qureshi N; Lee PC; Wu CK; Saechao C; Federman N; Li CY; Ritz B; Arah OA; Heck JE
Pediatr Blood Cancer; 2023 Mar; 70(3):e30188. PubMed ID: 36600459
[TBL] [Abstract][Full Text] [Related]
31. Correction of Fanconi Anemia Mutations Using Digital Genome Engineering.
Sipe CJ; Kluesner MG; Bingea SP; Lahr WS; Andrew AA; Wang M; DeFeo AP; Hinkel TL; Laoharawee K; Wagner JE; MacMillan ML; Vercellotti GM; Tolar J; Osborn MJ; McIvor RS; Webber BR; Moriarity BS
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955545
[TBL] [Abstract][Full Text] [Related]
32. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
33. Fanconi Anaemia, Childhood Cancer and the
Woodward ER; Meyer S
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680915
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility.
Martin-Giacalone BA; Weinstein PA; Plon SE; Lupo PJ
J Clin Med; 2021 May; 10(9):. PubMed ID: 34065162
[TBL] [Abstract][Full Text] [Related]
35. Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences.
García-de-Teresa B; Rodríguez A; Frias S
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33371494
[TBL] [Abstract][Full Text] [Related]
36. Genetic predisposition in pediatric oncology.
Pruteanu DP; Olteanu DE; Cosnarovici R; Mihut E; Nagy V
Med Pharm Rep; 2020 Oct; 93(4):323-334. PubMed ID: 33225257
[TBL] [Abstract][Full Text] [Related]
37. Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment.
Liu EK; Suson KD
Transl Androl Urol; 2020 Oct; 9(5):2370-2381. PubMed ID: 33209710
[TBL] [Abstract][Full Text] [Related]
38. Review: Ewing Sarcoma Predisposition.
Gargallo P; Yáñez Y; Juan A; Segura V; Balaguer J; Torres B; Oltra S; Castel V; Cañete A
Pathol Oncol Res; 2020 Oct; 26(4):2057-2066. PubMed ID: 31656020
[TBL] [Abstract][Full Text] [Related]
39. Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.
Steinberg-Shemer O; Goldberg TA; Yacobovich J; Levin C; Koren A; Revel-Vilk S; Ben-Ami T; Kuperman AA; Zemer VS; Toren A; Kapelushnik J; Ben-Barak A; Miskin H; Krasnov T; Noy-Lotan S; Dgany O; Tamary H
Haematologica; 2020 Jul; 105(7):1825-1834. PubMed ID: 31558676
[TBL] [Abstract][Full Text] [Related]
40. An update on the pathogenesis and diagnosis of Diamond-Blackfan anemia.
Da Costa L; Narla A; Mohandas N
F1000Res; 2018; 7():. PubMed ID: 30228860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
